INSMED Inc
INSMNasdaqCIK 1104506HealthcareFiscal year ends Dec 31
Reports and events: 362 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-041097 |
| 2026-10-2907:00 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001104506-26-000047 |
| 2026-10-2007:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-040177 |
| 2026-10-0507:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038529 |
| 2026-08-0607:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-031502 |
| 2026-08-0606:59 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104506-26-000041 |
| 2026-07-1607:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-028602 |
| 2026-05-1516:01 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-021648 |
| 2026-05-0707:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019430 |
| 2026-05-0707:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104506-26-000032 |
| 2026-04-0716:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-013659 |
| 2026-04-0116:01 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0001104506-26-000022 |
| 2026-03-2307:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-010651 |
| 2026-02-1907:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104506-26-000009 |
| 2026-02-1907:01 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-006116 |
| 2026-01-0907:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000778 |
| 2025-12-1716:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-045836 |
| 2025-11-1816:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-042598 |
| 2025-10-3007:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104506-25-000053 |
| 2025-10-3007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-039789 |
| 2025-08-1211:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-030537 |
| 2025-08-0707:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-029343 |
| 2025-08-0707:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001104506-25-000043 |
| 2025-06-1308:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-022375 |
| 2025-06-1007:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-022023 |
| 2025-06-0617:00 ET | 8-K | 8.01 Other events | 0001140361-25-021810 |
| 2025-05-1616:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001140361-25-019490 |
| 2025-05-0807:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017858 |
| 2025-05-0806:59 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001104506-25-000026 |
| 2025-04-2417:09 ET | 8-K/A | 8.01 Other events | 0001140361-25-015487 |
| 2025-04-2407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-015301 |
| 2025-04-1716:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-014376 |
| 2025-04-0408:15 ET | DEF 14A | Proxy statementPeriod 2025-05-15 | 0001104506-25-000018 |
| 2025-02-2408:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-005570 |
| 2025-02-2007:00 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005190 |
| 2025-02-2007:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001104506-25-000009 |
| 2025-02-0608:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-003266 |
| 2025-01-1008:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000711 |
| 2024-11-1908:00 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-24-047246 |
| 2024-10-3107:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-044703 |
| 2024-10-3107:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001104506-24-000033 |
| 2024-08-0917:30 ET | 8-K | 8.01 Other events | 0001140361-24-036671 |
| 2024-08-0807:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036279 |
| 2024-08-0807:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001104506-24-000026 |
| 2024-07-0309:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-032333 |
| 2024-06-2708:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-031492 |
| 2024-06-1308:00 ET | 8-K | 8.01 Other events | 0001140361-24-029955 |
| 2024-06-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-028710 |
| 2024-05-3017:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-028205 |
| 2024-05-2806:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-027535 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:15 ET. Listed shows no prices and gives no investment advice.